Manufacturing Disruption Impact
Norbrook, the sole manufacturer of Penicillin G Procaine, has recently experienced significant supply challenges with their injectable veterinary products due to manufacturing changes that resulted in a 60-day production disruption.
The disruption caused significant shortages, as Norbrook was already operating at full capacity to meet high market demand.
Current Supply Status
The company has returned to full manufacturing capacity and is beginning to release products to distributors. However, distribution is currently being managed through an allocation system to ensure equitable access across the market. Given the pre-existing demand pressures and the need to fulfill accumulated backorders, supply shortages are expected to persist for an extended period.
Recommended Actions for Producers
In response to these supply constraints, producers are strongly encouraged to consult with their veterinarians regarding potential protocol adjustments and alternative treatment options. Several alternative products, may serve as suitable substitutes.
Contact Information
For specific questions regarding product availability, alternative protocols, or technical guidance, veterinary professionals are encouraged to contact Norbrook’s technical service veterinarian or their designated sales representative. These professionals can provide tailored advice based on individual operational needs and clinical requirements.
